SAN DIEGO and SOLANA BEACH, Calif., April 2, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, and eMolecules, Inc, a market-leading compound sourcing platform, announced that they are collaborating to include eMolecules' in-stock building block compounds in the Accelrys Available Chemicals Directory (ACD) database. Adding eMolecules into Accelrys ACD enables scientists to identify the optimal set of compounds for their synthesis or library with increased confidence that those compounds will be available at the indicated prices from the selected suppliers.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-and-emolecules-collaborate-to-enhance-accelrys-available-chemicals-directory-200976961.html
"Now, with the inclusion of validated and curated compound availability information from eMolecules, Accelrys ACD customers can order with increased confidence that chemical suppliers will deliver the compounds on time," said Dr. Matt Hahn, senior vice president and chief technology officer, Accelrys. "Together, Accelrys and eMolecules are revolutionizing the efficiency and reliability of compound acquisition throughout our shared markets."
"This collaboration will help Accelrys ACD users acquire the in-stock compounds critical to their projects' progress in an efficient and easy way," said Niko Gubernator, CEO of eMolecules. "eMolecules is excited to demonstrate to Accelrys' ACD users how our revolutionary approach to compound purchasing has delivered industry-proven results in improving efficiencies, lowering costs and driving innovation for pharmaceutical, biotech and academic groups alike."The eMolecules online chemical compound sourcing platform has rapidly established itself as a market leader in enabling scientists to source and purchase commercially available 'in-stock' compounds reliably and efficiently. Accelrys ACD, used and trusted for more than 25 years by researchers in the global pharmaceutical, biotechnology, chemical and agrochemical sectors, enables scientists to access high quality curated and harmonized chemical property, availability and pricing information on 7.8 million compounds from 940 suppliers, with the information available via numerous delivery mechanisms including remotely hosted services.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts